News | July 13, 2022
Heathcare startup MedTel to raise around USD 10mn in Series A
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Medicines, including insulin, to be available in 40 lower-income countries
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
Both manufacturing facilities are based out of Benguluru, India
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
Subscribe To Our Newsletter & Stay Updated
